FDA — authorised 23 February 2000
- Marketing authorisation holder: ALCON PHARMS LTD
- Status: approved
🇺🇸 Betaxon in United States
FDA authorised Betaxon on 23 February 2000
Marketing authorisations
FDA — authorised 23 February 2000
- Application: NDA021114
- Marketing authorisation holder: ALCON PHARMS LTD
- Local brand name: BETAXON
- Indication: SUSPENSION/DROPS — OPHTHALMIC
- Status: approved
Betaxon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Betaxon approved in United States?
Yes. FDA authorised it on 23 February 2000; FDA authorised it on 23 February 2000.
Who is the marketing authorisation holder for Betaxon in United States?
ALCON PHARMS LTD holds the US marketing authorisation.